Nanjing Well Pharmaceutical Co Ltd
SSE:603351
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/S
Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.
Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.
Valuation Scenarios
If P/S returns to its 3-Year Average (2.9), the stock would be worth ¥27.68 (2% upside from current price).
| Scenario | P/S Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 2.8 | ¥27.14 |
0%
|
| 3-Year Average | 2.9 | ¥27.68 |
+2%
|
| 5-Year Average | 2.7 | ¥25.98 |
-4%
|
| Industry Average | 2.6 | ¥25.47 |
-6%
|
| Country Average | 2.8 | ¥26.82 |
-1%
|
Forward P/S
Today’s price vs future revenue
Peer Comparison
| Market Cap | P/S | P/E | ||||
|---|---|---|---|---|---|---|
| CN |
N
|
Nanjing Well Pharmaceutical Co Ltd
SSE:603351
|
3.7B CNY | 2.8 | 24.9 | |
| SA |
|
Saudi Basic Industries Corporation SJSC
SAU:2010
|
228.3B SAR | 2 | -8.8 | |
| ID |
|
Chandra Asri Pacific PT Tbk
OTC:PTPIF
|
45.6B USD | 6.5 | 41.8 | |
| US |
|
Dow Inc
NYSE:DOW
|
29B USD | 0.7 | -11.1 | |
| ID |
|
Chandra Asri Petrochemical Tbk PT
IDX:TPIA
|
458.5T IDR | 3.9 | 24.8 | |
| UK |
|
LyondellBasell Industries NV
NYSE:LYB
|
24B USD | 0.8 | -32.4 | |
| CN |
|
Hengli Petrochemical Co Ltd
SSE:600346
|
155.5B CNY | 0.8 | 17.4 | |
| TW |
|
Nan Ya Plastics Corp
TWSE:1303
|
710.6B TWD | 2.7 | 157.3 | |
| KR |
|
LG Chem Ltd
KRX:051910
|
31.1T KRW | 0.7 | -17.1 | |
| CN |
|
Rongsheng Petrochemical Co Ltd
SZSE:002493
|
139.4B CNY | 0.5 | 189.3 | |
| CN |
G
|
Guangzhou Tinci Materials Technology Co Ltd
SZSE:002709
|
123.1B CNY | 6.2 | 42.9 |
Market Distribution
| Min | 0 |
| 30th Percentile | 1.5 |
| Median | 2.8 |
| 70th Percentile | 5.4 |
| Max | 5 034 353.9 |
Other Multiples
Nanjing Well Pharmaceutical Co Ltd
Glance View
Nanjing Well Pharmaceutical Co., Ltd. engages in the development, production, and sale of pharmaceutical excipients and synthetic lubricating base oils. The company is headquartered in Nanjing, Jiangsu and currently employs 615 full-time employees. The company went IPO on 2019-01-30. Its main products include pharmaceutical auxiliary materials, synthetic lubricating base oil and pesticide additives. The firm distributes its products primarily in domestic market.
